VAKZINE PROJEKT MANAGEMENT GMBH

VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. The company was established in 2002 following an initiative of the German Federal Ministry of Education and Research to promote the German market by funding vaccine development. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs from academic research and brought them into clinical phase I and II trials.